Pacific Biosciences shares surge 13.38% intraday as genomics market growth report and Stephens price target raise to $2.00 drive optimism.

Pacific Biosciences surged 13.38% intraday trading as a November 20, 2025, report projected the global genomics market to grow from $47.07 billion in 2025 to $85.09 billion by 2030 at a 12.6% CAGR, highlighting strong industry growth. The company also participated in the Stephens annual investment conference and Jefferies Global Healthcare Conference on November 19, 2025, and Stephens raised its price target to $2.00 from $1.80, reflecting bullish expectations.